Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, opioid and Vertex Pharmaceuticals
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
Vertex: New non-opioid painkiller Journavx approved by FDA
The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, studies show it’s only modestly effective compared to opioid-acetaminophen combinations.
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
8h
on MSN
Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’
We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...
NBC News on MSN
12d
'Will it really work?': Young sickle cell patient among the first to start new gene therapy
Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Michigan priest loses license
Signs education orders
Ex-worker admits to theft
Hamas confirms death
Blames DEI for crash
'As Tears Go By' singer dies
2 more victims in indictment
Gun trafficking indictments
Jury weighs charges
Searching for joyriders
First spacewalk together
DOJ sues to block deal
S3 release date revealed
DOJ weighs dropping case?
US economy grew 2.3%
Syria’s transitional pres
Wildfire erupts in NC
Deputy shooting sentence
Day 2 of Senate hearing
Shiffrin finishes 10th
Plans job, output cuts in US
Senate confirmation hearing
Hamas frees more hostages
Partners w/ US national labs
Ebola outbreak in Uganda
Weekly jobless claims fall
Feedback